4//SEC Filing
Spoor Johan M. 4
Accession 0001415889-18-001121
CIK 0001604191other
Filed
Jul 15, 8:00 PM ET
Accepted
Jul 16, 9:08 PM ET
Size
5.6 KB
Accession
0001415889-18-001121
Insider Transaction Report
Form 4
Spoor Johan M.
DirectorPresident and CEO
Transactions
- Award
Common Stock
2018-07-12+200,000→ 300,034 total
Holdings
- 39,851(indirect: By Children)
Common Stock
Footnotes (1)
- [F1]Represents grant of restricted stock. Shares shall vest in increments as follows: (i) 1/6 upon the acceptance of a U.S. IND for MS 1819; (ii) 1/6 upon the the first CF patient dosed with MS1819 anywhere in the globe; (iii) 1/6 upon upon enrollment of the first 30 patients in a CF trial; (iv) 1/6 on July 12, 2019; (v) 1/6 on July 12, 2020; and (vi) 1/6 on July 12, 2021.
Documents
Issuer
AzurRx BioPharma, Inc.
CIK 0001604191
Entity typeother
Related Parties
1- filerCIK 0001535289
Filing Metadata
- Form type
- 4
- Filed
- Jul 15, 8:00 PM ET
- Accepted
- Jul 16, 9:08 PM ET
- Size
- 5.6 KB